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Background: Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease in industrialized countries.
The present study was undertaken to explore the preventive effect of dietary sea cucumber cerebroside (SCC)
extracted from Acaudina molpadioides in fatty liver rats.
Methods: Male Wistar rats were randomly divided into four groups including normal control group, NAFLD model
group, and two SCC-treated groups with SCC at 0.006% and 0.03% respectively. The fatty liver model was
established by administration of 1% orotic acid (OA) to the rats. After 10d, serum and hepatic lipid levels were
detected. And the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were also
determined. Besides, to gain the potential mechanism, the changes of key enzymes and gene expressions related
to the hepatic lipid metabolism were measured.
Results: Dietary SCC at the level of 0.006% and 0.03% ameliorated the hepatic lipid accumulation in fatty liver rats.
SCC administration elevated the serum triglyceride (TG) level and the ALT, AST activities in OA-fed rats. The activities
of hepatic lipogenic enzymes including fatty acid synthase (FAS), malic enzyme (ME) and glucose-6-
phosphatedehydrogenase (G6PDH) were inhibited by SCC treatment. And the gene expressions of FAS, ME, G6PDH
and sterol-regulatory element binding protein (SREBP-1c) were also reduced in rats fed SCC. However, dietary SCC
didn't affect the activity and mRNA expression of carnitine palmitoyltransferase (CPT) in liver. Besides, suppression of
microsomal triglyceride transfer protein (MTP) activity was observed in SCC-feeding rats.
Conclusions: These results suggested that dietary SCC could attenuate hepatic steatosis due to its inhibition of
hepatic lipogenic gene expression and enzyme activity and the enhancement of TG secretion from liver.
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The metabolic syndrome, a cluster of metabolic abnor-
malities such as hyperlipidemia, diabetes mellitus, and
hypertension, is a widespread disease in industrialized
countries and contributes to the increase in cardiovascu-
lar morbidity and mortality [1-3]. Nonalcoholic fatty
liver disease (NAFLD), an increasingly prevalent chronic
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reproduction in any medium, provided the orinsulin resistance and metabolic syndrome. NAFLD is
the preferred term to describe the spectrum of liver
damage ranging from hepatic steatosis to steatohepatitis,
liver fibrosis, and cirrhosis [4]. It has been reported that
occurrence of NAFLD ranges from 10% to 24% in differ-
ent populations, and even reaches 74% in obese indivi-
duals [5]. This prevalence prompted studies to focus on
the prevention or therapy of NAFLD. Though the pro-
cesses through which steatohepatitis evolves from hep-
atic steatosis are not fully understood, it is necessary to
develop effective therapies for the treatment of NAFLD
and to discover nutrients that will reduce the risk of
NAFLD.Ltd. This is an Open Access article distributed under the terms of the Creative
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synthesis, is known to evoke fatty liver when fed over an
appreciable amount in rats [6,7]. The model established
by OA-supplemented diet to rats reflects the natural
etiologic setting in which NAFLD develops[8]. OA-
induced NAFLD has been reported to be possibly gener-
ated, in part, by reduction of very low density lipoprotein
(VLDL) secretion [9], enhancement of triglyceride (TG)
synthesis [7,10] and decrease in fatty acid β- oxidation
[8,11,12]. The hepatic TG accumulation caused by OA
which has been demonstrated before was likely to be
alleviated by dietary nutrients. Buang Y has found that
dietay phosphatidylcholine alleviated OA-induced hep-
atic steatosis and hepatomegaly through downregulation
of fatty acid synthesis and up-regulation of β-oxidation
in rats [13]. Dietary saponins of sea cucumber attenu-
ating fatty liver partly associated with the promoted
lipolysis via PPARα activation and inhibited SREBP-1c-
mediated lipogenisis [12]. But no study was undertaken
to ascertain the influence of dietary glycolipids against
NAFLD.
The existence of glycolipids has been determined in
wide range. Early in 2000, Suzuki H has detected glycoli-
pids from several plants [14]. Recent growing interest in
the physiological functions of glycolipid as a nutrient in
food has generated. The antifungal and antibacterial ac-
tivities in the three sphingolipids isolated from cucum-
ber Cucumis sativus L. has been evaluated recently [15].
Glycolipids has been shown great anticancer potency
through inducing Th1-biased cytokines and CD8/CD4 T
cells in mice bearing breast and lung cancers [16].
Nakagawa R discovered that galactosylceramide acti-
vated NKT cells and then produced IFN-γ, which both
increased the innate antitumor cytotoxicity of NK cells
and expessed inhibition of tumor metastasis to liver
through the adaptive antitumor response of CD8+ T
cells in mice [17]. The effect of glycolipids on the immu-
nomodulatory has also been investigated peviously[18].
The cerebroside, a type of endogenous glycolipid exten-
sively existing in cell membranes of fungi, plants, ani-
mals and marine organism [19], has been proven to
exert pharmacological effects, such as antibacterial, anti-
hepatotoxic, anti-tumor and neuroprotective activities
[20-23]. And the cerebroside was also reported to regu-
late lipid levels according to Cohn Jeffrey [24]. The mar-
ine cerebroside displayed strong bioactivity as a result of
the special ocean circulation, although there are fewer
classes and lower contents of cerebrosides in marine
than living in the ground. Sea cucumber of Echinoder-
mata is an important marine food and medical material
in Asian countries. Researches on the influence of diet-
ary whole sea cucumber on lipid metabolism have been
much investigated. Tanaka K has found that dietary 5%
black sea cucumber (Stichophus japonicus) revealedhypolipidemic effect in rats [25]. The results of Wang's
study on sea cucumber (Pearsonothuria graeffei and
Apostichopus japonicus) displayed its lipid-lowering ef-
fect in hypercholesteremic rats [26]. However, it is un-
known whether the sea cucumber cerebroside (SCC)
may prevent against lipid metabolism disorder in animal
models.
Whereas the SCC may be expected to exhibit various
physiological functions based on the results obtained
from cerebrosides from other sources. Nonetheless,
reports on biological evaluation of lipid metabolism on
SCC are unavailable. Therefore, the present work was
carried out to discuss the effect of SCC on the lipids of
serum and liver in rats fed OA diet. To gain an insight
into the mechanism of SCC on the NAFLD caused by
OA, response of enzymatic activities and mRNA expres-
sion involved in hepatic lipid metabolism was also
measured.
Methods
Isolation and purification of cerebroside
The dried body wall of sea cucumber Acaudina molpa-
dioides was grinded to powder and extracted three times
with EtOH/H2O (4:1). The combined extracts were con-
centrated in vacuo to give an aqueous solution. The
aqueous solution was extracted with three portions of n-
hexane. The organic layer was concentrated in vacuo
and the residue was washed with cold acetone to give an
acetone-insoluble fraction. The acetone-insoluble part
was chromatographed on Silica gel column(solvent
CHCl3/MeOH 99:1 to CHCl3/MeOH/H2O 80:15:1) to
afford cerebrosides (purity ≥ 95%) [27]. The structure of
the SCC is shown in Figure 1.
Animals and diets
All aspects of the experiment were conducted according
to guidelines provided by the ethical committee of ex-
perimental animal care at Ocean University of China
(OUC, China).
Male Sprague–Dawley rats aged 5wk were purchased
from Vital River (Beijing, China) and housed individually
in an air-conditioned room with a 12-h light/dark cycle,
a constant temperature of 24°C and relative humidity of
65 ± 15%. After a 1-wk adaptation period, rats were ran-
domly divided into four groups (n = 6). The animals were
then assigned to the following four different diets: 1)
AIN-93 G diet (Cont); 2) AIN-93 G diet with 1% OA
contained (OA); 3) 1% OA-contained AIN-93 G diet
plus 0.006%SCC (OA+ 0.006%); 4) 1% OA-contained
AIN-93 G diet plus 0.03% SCC (OA+ 0.03%). Basal
experimental diets were prepared according to the
recommendations of the American Institute of Nutrition
(AIN). The composition of the diets and SCC concentra-
tion were shown in Table 1. Rats were allowed free
Figure 1 The structure of SCC from Acaudina molpadioides.
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feeding period, all rats were killed by bleeding from the
abdominal aorta under diethyl ether anesthesia after
overnight fasting. Serum was separated from the whole
blood by centrifugation at 1500*g for 10 min at 4°C.
Liver, perirenal adipose and epididymal adipose were im-
mediately excised for analysis.
Serum biochemistry analysis
Serum total cholesterol (TC), TG and low density lipo-
protein cholesterol (LDL-c) were measured using en-
zymatic reagent kits from Biosino (Beijing, China)
according to the manufacturer's instructions. Serum
ALT and AST activities were determined using enzym-
atic kits from Njjctech (Nanjing, China).
Measurement of hepatic lipid levels
Hepatic lipids were extracted and purified according to
the method of Folch [28] and then dissolved with 10%
Triton X-100. The concentrations of TG and TC inTable 1 Composition of experimental diets (g/kg diet)
Ingredients Cont OA OA+0.006 OA+0.03 %
Casein 200 200 200 200
Cornstarch 500 490 489.94 489.7
Sucrose 100 100 100 100
Corn oil 100 100 100 100
Mineral mix (AIN-93 G) 35 35 35 35
Vitamin mix(AIN-93 G) 10 10 10 10
Choline bitartrate 2 2 2 2
Cellulose 50 50 50 50
L-cystine 3 3 3 3
OA — 10 10 10
SCC — — 0.06 0.3
Vitamin mixture (AIN-93VX; DyetsInc.).
Mineral mixture (AIN-93 G; DyetsInc.).liver were detected using enzymatic reagent kits from
Biosino(Beijing, China), and the hepatic phospholipid
(PL) levels were determined according to the methods
of Bartlett [29].
Preparation of liver subcellular fractions and assays of
hepatic enzyme activities
Portions of the fresh livers from individual rats were
homogenized in ice-cold 0.25 M sucrose solution con-
taining 10 mM Tris–HCl buffer (pH7.4) and 1 mM
EDTA. After precipitating the nuclei fraction, the super-
natant was centrifuged at 10,000*g for 10 min at 4°C to
obtain mitochondria, which was used for carnitinepalmi-
toyl transferase (CPT) activity as described previously
[30]. The resulting supernatant was re-centrifuged at
125,000*g for 60 min,the supernatant (cytosol) was used
for the assays of fatty acid synthase (FAS), malic enzyme
(ME) and glucose-6-phosphatedehydrogenase (G6PDH)
activities as described [30-32], and the precipitate(micro-
somes) was used for the assays of microsomal triglycer-
ide transfer protein (MTP) activity with an MTP assay
kit from Roar Biomedical (New York, US). The protein
concentration was determined according to the method
of Lowry [33], with bovine serum albumin used as the
standard.
Determination of mRNA expression of hepatic genes
For analysis of gene expression, total cellular RNA was
extracted from 100 mg frozen liver samples using the
Trizol reagent (Invitrogen, USA) according to the manu-
facturer’s recommended procedures. RNA concentra-
tions were determined spectrophotometrically and 1 μg
total RNA was reverse transcribed using an MMLV re-
verse transcriptase kit (Promega, USA) and random pri-
mers (TOYOBO, Japan) in a reaction volume of 50uL
for cDNA synthesis. The concentration of cDNA was
analyzed by real-time detection PCR (ABI Prism 7500
Sequence Detection System, USA) using Sybr Green I
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with a final volume of 30 μL reaction mixture contain-
ing:15 μL master mix, 2 μL first-strand cDNA, 1 μL pri-
mer with each forward and reverse, and H2O to make
up 30 μL. A dilution curve from one cDNA source using
dilutions of 1:2, 1:4, 1:8 and a no-template control was
run for each gene including sterol- regulatory element
binding protein (SREBP-1c). The gene expression was
determined by relative quantification using the standard
curve method. A final melting curve guaranteed the au-
thenticity of the target product. The expression signal of
the house keeping gene ß -actin served as an internal
control for normalization.The primer sequences used for
real-time PCR were shown in Table 2.
Statistical analyses
All the values are expressed as mean± standard error of
the mean of six rats. All statistical analyses were per-
formed using PC SAS software. One-way ANOVA and
Tukey’s post hoc test with least significant difference
were used to compare group means. Homogeneity of
variances was tested by Levene’s test and Welch’s
ANOVA was used to compare group means when the
group variances were unequal. P< 0.05 was considered
statistically significant.
Results
Body weight gain, food intake, liver weight and adipose
weight
As described in Table 3, the initial body weight (BW)
was similar among the four groups. The amount of food
consumed and food intake were almost the same in the
period of experiment. OA feeding markedly elevated the
liver weight compared to the controls (P< 0.01), while
the rats fed with SCC resulted in a significant decrease
in liver weight as compared with the OA-feeding rats
(P< 0.05). There was no statistical difference among the
four groups in the adipose tissue weight although dietary
SCC slightly reduced the weight of perirenal adipose.
Serum and hepatic parameters
Table 4 summarized the lipid levels of the rats in serum








Gene-specific primers were designed by Primer Premier 5.0 software.the controls, the serum TG and TC concentrations
decreased (P< 0.05, P< 0.05) in the rats fed with OA,
while the LDL-c level tended to decrease without signifi-
cant difference. The rats in both SCC groups had higher
serumTGcontent thantheOA-fedrats (P< 0.05,P< 0.05) ,
but theTC and the LDL-c concentrations, although tended
to reduce, were of no statistic difference in the two groups
contrasting the OA group.
OA-feeding rats had a hepatic TG level four times
higher than that in the controls (P< 0.01). But SCC
supplementation at 0.006% and 0.03% in rats both
attenuated the OA-induced TG accumulation in con-
trast to the OA feeding (P< 0.05, P< 0.01). The same
tendency was observed in the hepatic TC level be-
tween the control and OA groups (P< 0.05); dietary
SCC at both doses reduced the TC concentration (P
< 0.05, P< 0.01) in comparison with the OA diet. The
PL content was of no marked difference among the
four groups.
Besides, rats fed OA diet displayed severe NAFLD-
accompanied liver injury. The activities of ALT
increased about 2-fold in the OA group as compared
with the controls (P< 0.01) and the AST increased
over 70% (P< 0.01). Administration of SCC at both
doses ameliorated the hepatic damage. Dietary SCC at
0.006% reduced the ALT and AST activities by 45.3%
and 25.6% respectively (P< 0.05, P< 0.05) and SCC at
0.03% by 44.6% and 27.6% separately (P< 0.05,
P< 0.05).Hepatic enzyme activities involved in lipogenesis
metabolism
OA administration increased the activities of FAS
(89.8%, P< 0.01), ME (24.6%, P< 0.05) and G6PDH
(72.8%, P< 0.05) in liver, while feeding SCC to NAFLD
rats significantly abolished the OA-induced increase.
Dietary SCC at 0.006% reduced the activity of FAS by
36.5% (P< 0.01) and G6PDH by 26.0% (P< 0.01), and
tended to decreased the activity of ME. Addition of SCC
at 0.03% significantly reduced the activities of FAS, ME
and G6PDH by 59.1% (P< 0.01), 42.8% (P< 0.01) and
30.9% (P< 0.01) (Figure 2).Accession No. Product length
AAAACG NM_031144 111 bp
CTA X62888 153 bp
TCC NM_012600 185 bp
CTC NM_031559 108 bp
C AF286470 166 bp
CT NM_012930 115 bp
Table 3 Effect of SCC on body weight gain, food intake, liver and adipose weights in rats
Cont OA OA+0.006 % OA+0.03 %
Initial BW, g 160± 7 160 ± 6 159 ± 8 158± 7
Final BW, g 248± 9 242 ± 8 238 ± 5 236± 9
Food intake, g/d 13.9 ± 0.3 13.8 ± 0.3 13.5 ± 0.7 13.2 ± 1.6
Liver index, g/100 g BW 3.77 ± 0.3 4.65 ± 0.4** 4.15 ± 0.3# 4.05 ± 0.2#
Perirenal adipose, g/100 g BW 0.85 ± 0.11 0.89 ± 0.15 0.84 ± 0.17 0.76 ± 0.21
Epididymal adipose,g/100 g BW 0.87 ± 0.04 0.90 ± 0.06 0.84 ± 0.12 0.87 ± 0.23
Rats were fed the experimental diets for 10d.
Values are expressed as mean± standard error of the mean of six rats. **P< 0.01 , different from the control group; #P< 0.05, different from the OA group.
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genes in liver
In order to explore the molecular mechanism of the ef-
fect of SCC on the regulation of fatty acid lipogenesis,
the expression of hepatic lipogenic genes was examined
(Figure 3). Considering the integrated lipid-lowering
effects of SCC, the group by dietary 0.03% SCC was
chosen to access the changes of the mRNA expression
for its most effective actions.
OA-supplemented diet to the rats up-regulated the
mRNA expression of the lipogenic transcription factor
SREBP-1c and its target genes (Figure 4). As compared
with the controls, OA group exhibited a 1.4-fold SREBP-
1c mRNA expreesion (P< 0.05), 1.3-fold FAS (P< 0.05)
and 1.4-fold G6PDH (P< 0.05); and the expression of
ME mRNA tended to increase without significant differ-
ence. Dietary SCC at 0.03% prevented the OA-stimulated
up-regulation of SREBP-1c and its response genes. SCC
supplementation down-regulated the mRNA expres-
sion of FAS, G6PDH and ME by 17.2% (P< 0.05), 43.0%
(P< 0.05) and 24%(P< 0.05).Table 4 Effect of SCC on serum and hepatic parameters in rat
Cont O
Serum lipids, mmol/L
TG 1.44 ± 0.14 0.69 ±
TC 1.75 ± 0.13 1.47 ±
LDL-c 1.53 ± 0.11 1.07 ±
Hepatic lipids, umol/g
TG 15.8 ± 1.3 97.3 ±
TC 19.2 ± 0.5 26.7 ±
PL 34.5 ± 1.2 32.7 ±
Enzyme activities, IU/L
ALT 9.21 ± 2.01 28.7 ±
AST 22.0 ± 1.76 39.5 ±
Rats were fed the experimental diets for 10d.
Values are expressed as mean± standard error of the mean of six rats.
*P< 0.05, **P< 0.01, different from the control group; #P< 0.05,##P< 0.01, differentHepatic CPT activity and mRNA expression
As depicted in Figure 4, 1% OA addition reduced the ac-
tivity of CPT, a key enzyme in fatty acid β-oxidation, by
37.1%(P< 0.05) as compared with the basal diet; The
SCC at both doses tended to attenuate the reduction
with no statistical difference. In line with the previous
results, SCC at 0.03% was selected for considering the
relative mRNA concentration of CPT1a. And consistent
with the change of CPT activity, the CPT1a mRNA ex-
pression reduced 11% (P< 0.05) due to the supplemented-
OA, but the SCC at 0.03% administration didn't affect
its expression over the OA diet.Hepatic MTP activity
To gain further insight into the relationship of ipid me-
tabolism between the liver and the serum, the activity of
MTP was detected (Figure 5). OA feeding markedly
inhibited the MTP activity (26.8%, P< 0.01), and SCC
at 0.03% significantly attenuated the inhibition by 30.2%
(P< 0.05) in contrast to the OA diet.s
A OA+0.006 % OA+0.03 %
0.12* 1.25 ± 0.09# 1.20 ± 0.13#
0.16* 1.54 ± 0.12 1.52 ± 0.10
0.15 1.19 ± 0.12 1.21 ± 0.13
3.5** 31.2 ± 6.7# 15.7 ± 2.9##
3.2* 17.5 ± 2.1# 14.3 ± 0.7##
1.3 33.2 ± 1.3 32.7 ± 1.5
5.13** 15.7 ± 1.76# 15.9 ± 1.93#
3.65** 29.4 ± 1.01# 28.1 ± 1.65#
from the OA group.
Figure 2 Effect of SCC on the activities of the enzymes related to fatty acid biosynthesis in rats. The activities of hepatic enzyme FAS, ME
and G6PDH in rats fed Cont or OA-supplemented diet or the diet with OA+ 0.006% SCC or OA+ 0.03% SCC for 10d. Values are expressed as
mean± standard error of the mean of six rats. *P< 0.05, **P< 0.01, different from the control group; ##P< 0.01, different from the OA group.
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OA administration is widely used in studies of the
mechanism of NAFLD. It is generally accepted that the
enhancement of de novo lipid synthesis and access ofFigure 3 Effect of SCC on the mRNA expression of lipogenic genes in
lipogenesis SREBP-1c, FAS, ME and G6PDH in rats fed Cont or OA-supplem
expressed as mean± standard error of the mean of six rats. *P< 0.05 , diffehepatic fatty acids and inhibition of VLDL assembly and
secretion result in OA-induced hepatic lipid accumula-
tion [34]. The main objective of this study was to clarify
if SCC contributed to NAFLD and to explore thethe liver of the rats. The mRNA expression of genes involved in
ented diet or the diet with OA+ 0.03% SCC for 10d. Values are
rent from the control group; #P< 0.05, different from the OA group.
Figure 4 Effect of SCC on the CPT enzyme activity and mRNA expression in the liver of the rats. The activtiy of CPT in rats fed Cont or
OA-supplemented diet or the diet with OA+ 0.006% SCC or OA+ 0.03% SCC and the mRNA expression of gene CPT1a in rats fed Cont or
OA-supplemented diet or the diet withOA+ 0.03% SCC for 10d. Values are expressed as mean± standard error of the mean of six rats.
*P< 0.05 , different from the control group.
Figure 5 Effect of SCC on the hepatic MTP activity in rats. The
activity of hepatic MTP in rats fed Cont or OA-supplemented diet or
the diet with OA+ 0.03% SCC for 10d. Values are expressed as
mean± standard error of the mean of six rats. **P< 0.01 , different
from the control group; #P< 0.05, different from the OA group.
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is a new nutrient that prevents the development of
NAFLD.
In the present study, dietary OA increased hepatic TG
content by 4-fold, indicating the establishment of
NAFLD model (Table 4). However, the raise in the hep-
atic TG concentration in rat was markedly reduced by
simultaneous feeding of SCC at the dose of 0.006% and
0.03%. The SCC at 0.03% decreased the lipid level to a
much lower extent. The same tendency was observed in
hepatic TC levels. The results above suggested that diet-
ary SCC improved hepatic lipid accumulation in a dose–
response manner.
In addition, OA resulted in hepatic lipid accumulation
and the increase in the activity of serum ALT and AST
(Table 4). This indicated OA-induced NAFLD accom-
panied hepatic injury in rats. Nonetheless dietary SCC
obviously attenuated the NAFLD-caused liver damage in
rats via the declination of ALT and AST activities. Those
results were in agreement with Zigmond E, who has
found thatβ-glycosphingolipids alleviated liver damage
through the immunomodulatory qualities inhibited local
inflammation in the response organ in Cohen diabetic
rats [35]. And to ourknowledg, this is the first report on
the beneficial effect of SCC on NAFLD and concomitant
liver injury in rats.
Several metabolic factors were involved in the hepatic
lipid accumulation and the stimulation of hepatic fatty
acid synthesis was the critical pathway of the NAFLD
development. Therefore, the activities of the enzyme
related to fatty acid biosynthesis were detected. And
from Figure 1, a marked increase in the activity of FAS,
a key enzyme involved in fatty acid synthesis, by OA diet
was observed, and the activities of NADPH-generating
enzymes required for FAS, ME and G6PDH, were also
increasingly altered by OA-feeding, which was accordantwith the study of Hu [12]. The present results demon-
strated that SCC intake significantly suppressed the ac-
tivities of those lipogenic enzymes, so one of the
possible lipid-lowering mechanisms of SCC may be the
inhibition of fatty acid biosynthesis.
As suggested in many researches, SREBP-1c acts a
major part in the pathogenesis of NAFLD. The genes
containing sterol-regulatory elements in their promoter
regions in the lipogenic pathway are regulated by
SREBP-1c including FAS, G6PDH and ME [36,37]. Over
expression of SREBP-1c produces a pronounced hepatic
TG accumulation leading to the development of NAFLD
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liver may potentially be responsible for the reduction of
hepatic TG accumulation. As Figure 2 presented,
SREBP-1c mRNA expression was strongly stimulated by
OA diet, and supplementation of SCC inhibited its ex-
pression. And accordingly, the mRNA expressions of
FAS, ME and G6PDH were concomitant markedly
decreased in rats fed by simultaneously OA and SCC.
Hence, the pathway of SCC-inhibition of lipogenis was
supposed that SCC supplementation directly affected the
SREBP-1c expression and then the alternation of these
lipogenic gene transcriptions occur, thus reducing the
activities of the responding enzymes. Another factor in
charge of OA-induced hepatic TG accumulation is a
declination of fatty acidβ-oxidation[12,40]. Since the
total β-oxidation critically depends on the mitochondrial
oxidation, the activity of the rate-limiting enzyme of
mitochondrial β-oxidation, CPT, was examined to reflect
the β-oxidation ability (Figure 4). Consistent with
Miyazawa S [41], dietary OA significantly decreased the
hepaticβ-oxidation capacity. However, SCC intake
showed no significantly effect on the key enzyme activ-
ities, although a slight increase was observed by dietary
SCC at both doses, especially at 0.03%. The result of
CPT1a mRNA expression was in accordance with the
enzyme changes among the four groups. So the mechan-
ism underlying the decrease in the activities of the lipo-
lytic enzyme following SCC consumption was limited
Morifuji M has reported that the dietary OA decreased
the level of serum TG [42]. In the present study, the
dietary OA suppressed the serum TG and TC levels, but
SCC intake significantly raised the depression (Table 4).
This result manifested that dietary SCC may contribute
to regulating the assembly and secretion of lipoprotein
in liver. MTP, a microsomal lumenal protein, is primarily
responsible for transfer of TG and other lipids from
their site of synthesis in the endoplasmic reticulum into
the lumen during the assembly of VLDL [43-45]. VLDL
produced by the liver are the major source of LDL in
plasma. So the increase of MTP activity and expression
accelerates the secretion of hepatic lipids in the form of
lipoprotein. Evidence in this study displayed that OA
supplementation significantly inhibited the MTP activity,
which also explained the lipid accumulation in liver
induced by dietary OA; While the SCC addition to the
fatty liver rats elevated the MTP activity (Figure 5),
which positively related to the increased serum lipid
levels and the decreased hepatic TG concent in the
SCC-feeding rats.Thus, this finding led to the suggestion
that the enhancement of TG secretion from liver was
another pathway of lipid-lowering mechanism of dietary
SCC.
In Gao’s study, the long chain base (LCB) of SCC exert
as much effect as the cerebroside itself in loweringhepatic lipid levels in mice, which suggests that the LCB
might take responsibility for the regulation of hepatic
lipid levels [46]. This result provides elementary refer-
ences for the relationship based on the structure and the
activity of the cerebroside but it still deserves further
investigation.
Conclusions
Supplementation with dietary SCC alleviated OA-
induced fatty liver by attenuating TG synthesis through
the down-regulation of fatty acid synthesis and improv-
ing TG secretion from liver. Findings of the present
study also supported that SCC might be useful in the
preservation of liver functions. But the relationship be-
tween the structure and the activity of the cerebroside
still requires further investigation.
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